image: Logo of the Algae4IBD project
Credit: European Science Communication Institute gGmbH
Cyanobacteria, micro- and macroalgae produce an infinite number of molecules, many of which have properties beneficial to health. They can relieve pain, alleviate inflammation, or boost our microbiome. Although there is much to uncover, the algae-based health and nutrition sector is growing.
The two-day summit will bring together scientists, innovators and industry leaders to explore the latest developments in algae cultivation and processing, food innovation, small molecules in pharma, and regulatory aspects. The goal is to advance the understanding of algae’s health potential and highlight how it can be applied across food and pharmaceutical sectors.
Algae for Health in Food and Pharma – Innovation and Industry Summit
Date: 4th & 5th March 2026
Location: Teagasc conference centre, Ashtown, Dublin, Ireland
The conference covers the industrial potential of algae and their bioactivities with a special focus on treating pain and inflammation. Other themes include the production and processing of algae as well as the development of functional foods, supplements and pharmaceuticals with compounds from algae.
The event provides a valuable platform for experts in the field of algae, food and pharma
-
to present their research during selected presentations
-
to showcase products and services of their company or start-up at booths.
The Algae for Health in Food and Pharma summit will create a space to exchange ideas and connect with key players in the growing algae-based health and nutrition sectors.
The networking initiative is funded by the Marine Institute under the Marine Research Programme with the support of the Government of Ireland, and is organised within the EU-funded Algae4IBD project. The Algae4IBD project isolates and characterises high-value molecules from algae to identify drug candidates and to develop food products that help prevent and treat pain and inflammation associated with inflammatory bowel disease (IBD).